亞太股份(002284.SZ):收到項目定點通知
格隆匯3月30日丨亞太股份(002284.SZ)公佈,公司於近日收到國外某新客户(因保密性要求,無法披露其名稱,以下簡稱“客户”)的定點通知,公司被定為該客户新平台的前卡鉗和鼓式制動器產品供應商。根據客户規劃,上述項目生命週期7年,預計將於2027年開始量產,生命週期銷售總金額預計約為8億元人民幣。
項目是公司新開發的國際客户平台項目,該定點為公司進軍海外市場奠定了良好的基礎,後續公司會積極地向該客户推廣公司的其他相關產品,大力拓展海外市場,進一步提升公司的國際競爭力。項目量產後,每年收入將根據該客户當年實際訂單情況進行確認,預計對公司本年度的收入及利潤水平暫無重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.